Vertex Pharmaceuticals
VRTX
VRTX
1,217 hedge funds and large institutions have $68B invested in Vertex Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 186 funds opening new positions, 432 increasing their positions, 438 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $68.6B → $68B (-$597M)
1% less repeat investments, than reductions
Existing positions increased: 432 | Existing positions reduced: 438
31% less funds holding in top 10
Funds holding in top 10: 39 → 27 (-12)
Holders
1,217
Holding in Top 10
27
Calls
$420M
Puts
$390M
Top Buyers
| 1 | +$185M | |
| 2 | +$182M | |
| 3 | +$144M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$125M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120M |
Top Sellers
| 1 | -$467M | |
| 2 | -$383M | |
| 3 | -$347M | |
| 4 |
BlackRock
New York
|
-$289M |
| 5 |
Lazard Asset Management
New York
|
-$139M |